Francis Collins
Francis Collins
Francis Sellers Collinsis an American physician-geneticist noted for his discoveries of disease genes and his leadership of the Human Genome Project. He is director of the National Institutes of Healthin Bethesda, Maryland, USA...
NationalityAmerican
ProfessionScientist
Date of Birth14 April 1950
CountryUnited States of America
academic bunch engine exercise gene nerdy transform
This is not just an academic exercise by a bunch of nerdy gene hunters. This is the engine that will transform medicine.
atoms aware certain chemicals food hard including molecules since
I'm aware there are certain products that are being advertised - food products - with 'no chemicals whatsoever.' Well, that would be pretty hard to arrange, since everything around us is made up of atoms and molecules - chemicals - including ourselves.
accelerate conditions consequences difficult discovery five genetic genome nail next power process producing project rather three tools
Conditions that we know have genetic contributions but which have been rather difficult to nail down, this set of power tools that the genome project is producing will accelerate this discovery process rather dramatically, and we're going to see the consequences of that in the next three to five years,
compared genome learn main opportunity pair precise programs public talking textbook today
This is a pair of programs where the public is the main winner. The genome has been compared to a textbook, and what we're talking about today is an opportunity to learn how to read that textbook in a more precise way.
capable cells children developed dramatic hallmark nuclear originally structure
FTIs, originally developed for cancer, are capable of reversing the dramatic nuclear structure abnormalities that are the hallmark of cells from children with progeria,
mathematician physicist
God is an awesome mathematician and physicist.
wall couple dark
The problem [with genetic research] is, we're just starting down this path, feeling our way in the dark. We have a small lantern in the form of a gene, but the lantern doesn't penetrate more than a couple of hundred feet. We don't know whether we're going to encounter chasms, rock walls or mountain ranges along the way. We don't even know how long the path is.
nerves aviation airmen
The airman must possess absolutely untroubled nerves.
numbers forever trying
A lot of science doesn't require big "ns" but if you're trying to understand something about human health and you're looking at interventions that are not going to be either killing you or making you live forever - they're going to have some tweaking on the outcome - you need big numbers or you don't have enough power.
consider historians profound responsibility turning
What a profound responsibility it is to do this work. Historians will consider this a turning point.
atheist reading years
As an atheist evolving to agnosticism, and seeking answers to whether or not belief in God is potentially rational, my life was turned upside down 35 years ago by reading C. S. Lewis's Mere Christianity.
prayer opportunity trying
Prayer is, for me, not an opportunity to ask God to do stuff for me. Prayer is an opportunity to open myself, to try and understand his will, and oftentimes it's a prayer of thanksgiving, and sometimes it's a prayer of supplication, and sometimes it is just worship.
atheist atheism argument
Addressing the conclusions of The God Delusion point by point with the devastating insight of a molecular biologist turned theologian, Alister McGrath dismantles the argument that science should lead to atheism, and demonstrates instead that Dawkins has abandoned his much-cherished rationality to embrace an embittered manifesto of dogmatic atheist fundamentalism.
fda people drug
When a drug comes out [that's broadly prescribed] there are going to start to be a lot of people on it [in a million person cohort] and you might get therefore an early signal of something unexpected that hadn't come through in the clinical trials. And I'm sure [drug companies] would love it if, in fact, FDA, recognizing that, would say, OK, maybe you don't have to do your trial with 30,000 people because we're going to find out shortly after registration because we'll have a lot of people taking the drug and we'll be able to see what happened using PMI.